Automated assessment of the substantia nigra on susceptibility map-weighted imaging using deep convolutional neural networks for diagnosis of Idiopathic Parkinson's disease
- PMID: 33761389
- DOI: 10.1016/j.parkreldis.2021.03.004
Automated assessment of the substantia nigra on susceptibility map-weighted imaging using deep convolutional neural networks for diagnosis of Idiopathic Parkinson's disease
Abstract
Objectives: Despite its use in determining nigrostriatal degeneration, the lack of a consistent interpretation of nigrosome 1 susceptibility map-weighted imaging (SMwI) limits its generalized applicability. To implement and evaluate a diagnostic algorithm based on convolutional neural networks for interpreting nigrosome 1 SMwI for determining nigrostriatal degeneration in idiopathic Parkinson's disease (IPD).
Methods: In this retrospective study, we enrolled 267 IPD patients and 160 control subjects (125 patients with drug-induced parkinsonism and 35 healthy subjects) at our institute, and 24 IPD patients and 27 control subjects at three other institutes on approval of the local institutional review boards. Dopamine transporter imaging served as the reference standard for the presence or absence of abnormalities of nigrosome 1 on SMwI. Diagnostic performance was compared between visual assessment by an experienced neuroradiologist and the developed deep learning-based diagnostic algorithm in both internal and external datasets using a bootstrapping method with 10000 re-samples by the "pROC" package of R (version 1.16.2).
Results: The area under the receiver operating characteristics curve (AUC) (95% confidence interval [CI]) per participant by the bootstrap method was not significantly different between visual assessment and the deep learning-based algorithm (internal validation, .9622 [0.8912-1.0000] versus 0.9534 [0.8779-0.9956], P = .1511; external validation, 0.9367 [0.8843-0.9802] versus 0.9208 [0.8634-0.9693], P = .6267), indicative of a comparable performance to visual assessment.
Conclusions: Our deep learning-based algorithm for assessing abnormalities of nigrosome 1 on SMwI was found to have a comparable performance to that of an experienced neuroradiologist.
Keywords: Deep learning; Magnetic resonance imaging; Nigrosome; Substantia nigra.
Copyright © 2021 Elsevier Ltd. All rights reserved.
Similar articles
-
A preliminary attempt to visualize nigrosome 1 in the substantia nigra for Parkinson's disease at 3T: An efficient susceptibility map-weighted imaging (SMWI) with quantitative susceptibility mapping using deep neural network (QSMnet).Med Phys. 2020 Mar;47(3):1151-1160. doi: 10.1002/mp.13999. Epub 2020 Jan 30. Med Phys. 2020. PMID: 31883389
-
Imaging of nigrosome 1 in substantia nigra at 3T using multiecho susceptibility map-weighted imaging (SMWI).J Magn Reson Imaging. 2017 Aug;46(2):528-536. doi: 10.1002/jmri.25553. Epub 2016 Nov 11. J Magn Reson Imaging. 2017. PMID: 27859983
-
Deep Learning-Based Algorithm for Automatic Quantification of Nigrosome-1 and Parkinsonism Classification Using Susceptibility Map-Weighted MRI.AJNR Am J Neuroradiol. 2025 May 2;46(5):999-1006. doi: 10.3174/ajnr.A8585. AJNR Am J Neuroradiol. 2025. PMID: 39547802
-
Nigrosome 1 imaging: technical considerations and clinical applications.Br J Radiol. 2019 Sep;92(1101):20180842. doi: 10.1259/bjr.20180842. Epub 2019 Jun 5. Br J Radiol. 2019. PMID: 31067082 Free PMC article. Review.
-
Loss of Nigral Hyperintensity on 3 Tesla MRI of Parkinsonism: Comparison With (123) I-FP-CIT SPECT.Mov Disord. 2016 May;31(5):684-92. doi: 10.1002/mds.26584. Epub 2016 Mar 17. Mov Disord. 2016. PMID: 26990970 Review.
Cited by
-
Classification of Parkinson's disease by deep learning on midbrain MRI.Front Aging Neurosci. 2024 Aug 20;16:1425095. doi: 10.3389/fnagi.2024.1425095. eCollection 2024. Front Aging Neurosci. 2024. PMID: 39228827 Free PMC article.
-
External Validation of Deep Learning Algorithms for Radiologic Diagnosis: A Systematic Review.Radiol Artif Intell. 2022 May 4;4(3):e210064. doi: 10.1148/ryai.210064. eCollection 2022 May. Radiol Artif Intell. 2022. PMID: 35652114 Free PMC article.
-
Editorial: Contribution of artificial intelligence-based tools to the study of Parkinson's disease and other movement disorders.Front Aging Neurosci. 2025 Mar 4;17:1567706. doi: 10.3389/fnagi.2025.1567706. eCollection 2025. Front Aging Neurosci. 2025. PMID: 40103925 Free PMC article. No abstract available.
-
Harnessing artificial intelligence for brain disease: advances in diagnosis, drug discovery, and closed-loop therapeutics.Front Neurol. 2025 Jul 28;16:1615523. doi: 10.3389/fneur.2025.1615523. eCollection 2025. Front Neurol. 2025. PMID: 40791911 Free PMC article. Review.
-
Neuroimaging and fluid biomarkers in Parkinson's disease in an era of targeted interventions.Nat Commun. 2024 Jul 5;15(1):5661. doi: 10.1038/s41467-024-49949-9. Nat Commun. 2024. PMID: 38969680 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical